The ability of Novasign to quickly adapt to customer's needs relies both on a young and motivated core team, and on the knowledge and network of the advisory board. Therefore, the structure of the company can be compared to their core product: Hybridmodels
Dr. Mark Dürkop
With more than nine years of experience, Mark is a passionated scientist in the field of biopharmaceutical process development for industries. He worked together with Novartis and Boehringer-Ingelheim targeting their needs in process development and understanding. After his PhD he decided to found a company together with other enthusiastic engineers from the fields of process modeling and control. Together they want to turn their passion into a career.
Benjamin Bayer, Msc.
Benjamin started his early academic career in the field of biomedicine, biotechnology, and molecular biology. Currently, he is developing bioprocess models while doing his Ph.D. in bioprocess engineering at the University of Natural Resources and Life Sciences in Vienna. His main emphasis is on upstream processing with a focus on hybrid modeling and Quality by Design implementation to support the mission of Novasign
Roger Dalmau Diaz, Msc.
Roger graduated in Industrial Electronics and Automatic Control Engineering at the Polytechnic University of Catalonia (UPC - EUETIB) and a master in Industrial Engineering (speciality Electrical, UPC - ETSEIAT). He is working on the implementation of the Novasign toolboxes and the design, programming and automation of laboratory equipment.
Maximilian Krippl, Msc.
Maximilian is a trained Downstream Process Engineer. He is currently developing hybrid-models to describe TFF systems while also working on his PhD at the University of Natural Resources and Life Sciences. Maximilian holds a Master Degree in Technical Chemistry from the University of Technology Vienna
Assoc. Prof. Dr. Gerald Striedner
Gerald is an Associate Professor at the Department of Biotechnology (BOKU), head of the working group microbial fermentation, and principal investigator in the Austrian Center of Industrial Biotechnology (ACIB). His working group has established an integrated systems approach for bioprocess development and is focused on the implementation of PAT and QbD concepts in bioprocessing and rational host cell design. CHO, E. coli, insect cells and vero cell lines are used as expression systems for production of a representative set of biopharmaceuticals (mABs, Fabs, scFvs, VLPs, DNA)
Dr. Moritz von Stosch
Moritz is a process systems engineer by education with a degree in Chemical Engineering from the RWTH-Aachen University (Germany), and PhD in Biochemical Engineering from the University of Porto (Portugal). Moritz worked as a Lecturer at the School of Chemical Engineering and Advanced Materials at Newcastle University, where his research focused on the development of intensified Design of Experiment approaches and novel hybrid modeling methods as well as their application to enable more efficient process operation/design. He has contributed to more than 25 publications in international peer-reviewed journals.
Dipl. Ing. Martin Mayer
With over 20 years of automation experience in different fields including traffic control systems, paper and steel production automation as well as biotechnology, Martin developed a true passion for business development. Within his current position at Eppendorf he is responsible for driving digitalization towards new solutions from smart devices to cloud based services.
Assoc. Prof. Rui Manuel Freitas Oliveira, Ph.D.
Rui is an Associate Professor at the Faculty of Sciences and Technology at UNL, Lisbon where he lectures Biochemical Engineering, Systems Biology and Synthetic Biology courses. As the head of the Systems Biology and Engineering research Lab he published more than 60 reviewed papers in scientific journals and more than 200 conference papers in the area of Systems Biotechnology.
Dr. Astrid Dürauer
Astrid is a key researcher and lecturer for bioprocess engineering at the University of Natural Resources and Life Sciences Vienna and within the Austrian Centre of Industrial Biotechnology (acib). She is head deputy of the working group “Protein technology and downstream processing”. Currently, her main focus is integrated process development considering the engineering aspect of non-chromatographic downstream processes, their scalability with special interest on miniaturization and automation as well as the set-up of online monitoring and control strategies.
Dr. Markus Luchner
Markus is expert in bioprocess engineering and fermentation technology at the University of Natural Resources and Life Sciences Vienna. He is head of the “BioIndustrial Pilot Plant” at the Department of Biotechnology. He is also expert in online monitoring systems, process modeling and control, process automation systems, scale-up and large scale production in a GMP environment.
Students and Part-time
Lina Vranitzky, Bsc.
Lina is doing her Master in Biotechnology at the University of Natural Resources and Life Sciences in Vienna. She is currently working on her Master Thesis in the field of upstream process development applying iDoE, thereby supporting the Novasgin approach of Quality-by-Design implementation and experimental Design of fermentations.
Partners and cooperations
The University of Natural Ressources and Life Science in Vienna (BOKU) is the spin-off partner of Novasign. Embedded in the dedicated Spin-off center of the university Novasign could develop its technology to market readiness.
Evon GmbH is specialized in process automation. Delivering solutions for home, traffic and industry automation the company is rapidly growing. With a strong MES system applied for different process industries Evon is the perfect partner for a modeling company like Novasign.
Igor Škrjanc is professor of Control Engineering at the faculty of electrical engineering at the University of Ljubljana. His main research areas are adaptive, predictive, neuro-fuzzy and fuzzy adaptive control systems. The first prototype of the software was developed in Igor's lab.